Thalassaemia belongs to a family of genetic conditions affecting the human blood, known as Haemoglobin disorders or Haemoglobinopathies. Haemoglobin disorders are a group of conditions affecting haemoglobin, an important substance or protein of the human blood contained in the red blood cells, hence the name haemoglobin disorders or haemoglobinopathies.
Haemoglobin disorders, including thalassaemia are an international concern. It is estimated that 7% of the world population is a carrier of a severe haemoglobin disorder and 300-500.000 children are born with a severe haemoglobin disorder each year. Research advances in the clinical care of thalassaemia have managed to transform thalassaemia from a fatal disease of childhood that it once was into a chronic, yet well-managed disease, increasing patients’ survival rate and improving their quality of life.